Abstract: Ulcerative colitis (UC) is an inflammatory condition of the intestine, resulting from an increase in oxidative stress and pro-inflammatory mediators. In this study, the extract of endophytic bacteriumRhizobium aegyptiacum was prepared for the first time using liquid chromatography-mass spectrometry (LC-MS). In addition, also for the first time, the protective potential ofR. aegyptiacum was revealed using an in vivo rat model of UC. The animals were grouped into four categories: normal control (group I),R. aegyptiacum (group II), acetic acid (AA)‍-induced UC (group III), and R. aegyptiacum-treated AA-induced UC (group IV). In group IV,R. aegyptiacum was administered at 0.2 mg/kg daily for one week before and two weeks after the induction of UC. After sacrificing the rats on the last day of the experiment, colon tissues were collected and subjected to histological, immunohistochemical, and biochemical investigations. There was a remarkable improvement in the histological findings of the colon tissues in group IV, as revealed by hematoxylin and eosin (H&E) staining, Masson’s trichrome staining, and periodic acid-Schiff (PAS) staining. Normal mucosal surfaces covered with a straight, intact, and thin brush border were revealed. Goblet cells appeared magenta in color, and there was a significant decrease in the distribution of collagen fibers in the mucosa and submucosal connective tissues. All these findings were comparable to the respective characteristics of the control group. Regarding cyclooxygenase-2 (COX-2) immunostaining, a weak immune reaction was shown in most cells. Moreover, the colon tissues were examined using a scanning electron microscope, which confirmed the results of histological assessment. A regular polygonal unit pattern was seen with crypt orifices of different sizes and numerous goblet cells. Furthermore, the levels of catalase (CAT), myeloperoxidase (MPO), nitric oxide (NO), interleukin-6 (IL-6), and interlukin-1β (IL-1β) were determined in the colonic tissues of the different groups using colorimetric assay and enzyme-linked immunosorbent assay (ELISA). In comparison with group III, group IV exhibited a significant rise (P<0.05) in the CAT level but a substantial decline (P<0.05) in the NO, MPO, and inflammatory cytokine (IL-6 and IL-1β) levels. Based on reverse transcription-quantitative polymerase chain reaction (RT-qPCR), the tumor necrosis factor-‍α (TNF-‍α) gene expression was upregulated in group III, which was significantly downregulated (P<0.05) by treatment withR. aegyptiacum in group IV. On the contrary, the heme oxygenase-1 (HO-1) gene was substantially upregulated in group IV. Our findings imply that the oral consumption ofR. aegyptiacum ameliorates AA-induced UC in rats by restoring and reestablishing the mucosal integrity, in addition to its anti-oxidant and anti-inflammatory effects. Accordingly,R. aegyptiacum is potentially effective and beneficial in human UC therapy, which needs to be further investigated in future work.

内生菌Rhizobium aegyptiacum对大鼠溃疡性结肠炎的潜在保护性治疗效果研究

[1]AbdallahHMI,AmmarNM,AbdelhameedMF,et al.,2020.Protective mechanism ofAcacia saligna butanol extract and its nano-formulations against ulcerative colitis in rats as revealed via biochemical and metabolomic assays.Biology (Basel),9(8):195.

[2]AbdelazizA,SonbolF,ElbannaT,et al.,2019.Exposure to sublethal concentrations of benzalkonium chloride induces antimicrobial resistance and cellular changes inKlebsiellae pneumoniae clinical isolates.Microb Drug Resist,25(5):631-638.

[3]AdaminaM,FeakinsR,IacucciM,et al.,2021.ECCO topical review optimising reporting in surgery, endoscopy, and histopathology: collaboration between S-ECCO, EduCom, H-ECCO.J Crohns Colitis,15(7):1089-1105.

[4]AlherzFA,NegmWA,ElekhnawyE,et al.,2022.Silver nanoparticles prepared usingEncephalartos laurentianus De Wild leaf extract have inhibitory activity againstCandida albicans clinical isolates.J Fungi (Basel),8(10):1005.

[5]AlmukainziM,El-MasryTA,NegmWA,et al.,2022.Co-delivery of gentiopicroside and thymoquinone using electrospun m-PEG/PVP nanofibers: in-vitro and in vivo studies for antibacterial wound dressing in diabetic rats.Int J Pharm,625:122106.

[6]AlotaibiB,El-MasryTA,ElekhnawyE,et al.,2022.Aqueous core epigallocatechin gallate PLGA nanocapsules: characterization, antibacterial activity against uropathogens, andin vivo reno-protective effect in cisplatin induced nephrotoxicity.Drug Deliv,29(1):1848-1862.

[7]AnsariMN,RehmanNU,KarimA,et al.,2021.Role of oxidative stress and inflammatory cytokines (TNF-α and IL-6) in acetic acid-induced ulcerative colitis in rats: ameliorated byOtostegia fruticosa.Life (Basel),11(3):195.

[8]AttallahNGM,Al-FakhranyOM,ElekhnawyE,et al.,2022a.Anti-biofilm and antibacterial activities ofCycas media R.Br secondary metabolites:in silico, in vitro, and in vivo approaches. Antibiotics (Basel),11(8):993.

[9]AttallahNGM,El-SherbeniSA,El-KademAH,et al.,2022b.Elucidation of the metabolite profile ofYucca gigantea and assessment of its cytotoxic, antimicrobial, and anti-inflammatory activities.Molecules,27(4):1329.

[10]AzizN,KimMY,ChoJY,2018.Anti-inflammatory effects of luteolin: a review of in vitro, in vivo, and in silico studies.J Ethnopharmacol,225:342-358.

[11]BancroftJD,GambleM,2008.Theory and Practice of Histological Techniques, 6th Ed.Churchill Livingstone,Philadelphia, USA.

[12]Ben-HorinS,NovackL,MaoR,et al.,2022.Efficacy of biologic drugs in short-duration versus long-duration inflammatory bowel disease: a systematic review and an individual-patient data meta-analysis of randomized controlled trials.Gastroenterology,162(2):482-494.

[13]BertevelloPL,LogulloÂF,NonogakiS,et al.,2005.Immunohistochemical assessment of mucosal cytokine profile in acetic acid experimental colitis.Clinics (Sao Paulo),60(4):277-286.

[14]BlacherE,LevyM,TatirovskyE,et al.,2017.Microbiome-modulated metabolites at the interface of host immunity.J Immunol,198(2):572-580.

[15]BruscoliS,FeboM,RiccardiC,et al.,2021.Glucocorticoid therapy in inflammatory bowel disease: mechanisms and clinical practice.Front Immunol,12:691480.

[16]ChecaJ,AranJM,2020.Reactive oxygen species: drivers of physiological and pathological processes.J Inflamm Res,13:1057-1073.

[17]DignassA,EliakimR,MagroF,et al.,2012.Second European evidence-based consensus on the diagnosis and management of ulcerative colitis part 1: definitions and diagnosis.J Crohns Colitis,6(10):965-990.

[18]ElekhnawyE,NegmWA,2022.The potential application of probiotics for the prevention and treatment of COVID-19.Egypt J Med Hum Genet,23:36.

[19]ElmongyEI,NegmWA,ElekhnawyE,et al.,2022.Antidiarrheal and antibacterial activities of Monterey cypress phytochemicals: in vivo and in vitro approach.Molecules,27(2):346.

[20]FanMM,XiangG,ChenJW,et al.,2020.Libertellenone M, a diterpene derived from an endophytic fungus Phomopsis sp. S12,protects against DSS-induced colitis via inhibiting both nuclear translocation of NF-κB and NLRP3 inflammasome activation. Int Immunopharmacol,80:106144.

[21]GautamMK,GoelS,GhatuleRR,et al.,2013.Curative effect ofTerminalia chebula extract on acetic acid-induced experimental colitis: role of antioxidants, free radicals and acute inflammatory marker.Inflammopharmacology,21(5):377-383.

[22]HsiaoYP,ChenHL,TsaiJN,et al.,2021.Administration ofLactobacillus reuteri combined withClostridium butyricum attenuates cisplatin-induced renal damage by gut microbiota reconstitution, increasing butyric acid production, and suppressing renal inflammation.Nutrients,13(8):2792.

[23]KaurL,GordonM,BainesPA,et al.,2020.Probiotics for induction of remission in ulcerative colitis.Cochrane Database Syst Rev,3(3):CD005573.

[24]KhairyH,SalehH,BadrAM,et al.,2018.Therapeutic efficacy of osthole against dinitrobenzene sulphonic acid induced-colitis in rats.Biomed Pharmacother,100:42-51.

[25]KhareT,PalakurthiSS,ShahBM,et al.,2020.Natural product-based nanomedicine in treatment of inflammatory bowel disease.Int J Mol Sci,21(11):3956.

[26]LaneDJ,1991.16S/23S rRNA sequencing. In: Stackebrandt E, Goodfellow M (Eds.),Nucleic Acid Techniques in Bacterial Systematics.John Wiley & Sons,Chichester, p.115-147.

[27]LavelleA,SokolH,2020.Gut microbiota-derived metabolites as key actors in inflammatory bowel disease.Nat Rev Gastroenterol Hepatol,17(4):223-237.

[28]le LouppAG,Bach-NgohouK,BourreilleA,et al.,2015.Activation of the prostaglandin D2 metabolic pathway in Crohn’s disease: involvement of the enteric nervous system.BMC Gastroenterol,15:112.

[29]LiX,LiuX,ZhangYF,et al.,2020.Protective effect of Gloeostereum incarnatum on ulcerative colitis via modulation of Nrf2/NF-κB signaling in C57BL/6 mice.Mol Med Rep,22(4):3418-3428.

[30]LiuXL,DongMS,ChenXH,et al.,2007.Antioxidant activity and phenolics of an endophyticXylaria sp.from Ginkgo biloba. Food Chem,105(2):548-554.

[31]LiuY,WeiWH,LiangSW,et al.,2022.Esculentoside A could attenuate apoptosis and inflammation in TNBS-induced ulcerative colitis via inhibiting the nuclear translocation of NF-κB.Ann Transl Med,10(14):771.

[32]LivakKJ,SchmittgenTD,2001.Analysis of relative gene expression data using real-time quantitative PCR and the2-ΔΔCTmethod.Methods,25(4):402-408.

[33]MiH,LiuFB,LiHW,et al.,2017.Anti-inflammatory effect of Chang-An-Shuan on TNBS-induced experimental colitis in rats.BMC Complement Altern Med,17:315.

[34]PeyrottesA,CoquantG,BrotL,et al.,2020.Anti-inflammatory effects of analogues ofN-acyl homoserine lactones on eukaryotic cells.Int J Mol Sci,21(24):9448.

[35]Piechota-PolanczykA,FichnaJ,2014.Review article: the role of oxidative stress in pathogenesis and treatment of inflammatory bowel diseases.Naunyn Schmiedebergs Arch Pharmacol,387(7):605-620.

[36]PopovJ,CaputiV,NandeeshaN,et al.,2021.Microbiota-immune interactions in ulcerative colitis and colitis associated cancer and emerging microbiota-based therapies.Int J Mol Sci,22(21):11365.

[37]Quettier-DeleuC,GressierB,VasseurJ,et al.,2000.Phenolic compounds and antioxidant activities of buckwheat (Fagopyrum esculentum Moench) hulls and flour.J Ethnopharmacol,72(1-2):35-42.

[38]RaishM,ShahidM,Bin JardanYA,et al.,2021.Gastroprotective effect of sinapic acid on ethanol-induced gastric ulcers in rats: involvement of Nrf2/HO-1 and NF-κB signaling and antiapoptotic role.Front Pharmacol,12:622815.

[39]RanZH,ChenC,XiaoSD,2008.Epigallocatechin-3-gallate ameliorates rats colitis induced by acetic acid.Biomed Pharmacother,62(3):189-196.

[40]RanaKL,KourD,KaurT,et al.,2020.Endophytic microbes: biodiversity, plant growth-promoting mechanisms and potential applications for agricultural sustainability.Antonie van Leeuwenhoek,113(8):1075-1107.

[41]ShahidM,RaishM,AhmadA,et al.,2022.Sinapic acid ameli

[42]orates acetic acid-induced ulcerative colitis in rats by suppressing inflammation,stressoxidative, andapoptosis.Molecules,27(13):4139.

[43]SinghM,KumarA,SinghR,et al.,2017.Endophytic bacteria: a new source of bioactive compounds.3Biotech,7(5):315.

[44]StrobelG,DaisyB,2003.Bioprospecting for microbial endophytes and their natural products.Microbiol Mol Biol Rev,67(4):491-502.

[45]TwaijBM,HasanMN,2022.Bioactive secondary metabolites from plant sources: types, synthesis, and their therapeutic uses.Int J Plant Biol,13(1):4-14.

[46]VavrickaSR,BrunL,BallabeniP,et al.,2011.Frequency and risk factors for extraintestinal manifestations in the Swiss inflammatory bowel disease cohort.Am J Gastroenterol,106(1):110-119.

[47]WangD,DuBoisRN,2010.The role of COX-2 in intestinal inflammation and colorectal cancer.Oncogene,29(6):781-788.

[48]WangQH,ZhiTX,HanPP,et al.,2021.Potential anti-inflammatory activity of walnut protein derived peptide leucine-proline-phenylalanine in lipopolysaccharides-irritated RAW264.7 cells.Food Agric Immunol,32(1):663-678.

[49]XueJC,YuanS,HouXT,et al.,2023.Natural products modulate NLRP3 in ulcerative colitis.Front Pharmacol,14:1265825.